← Back to Search

Laser Therapy

Laser Treatment for Radiation Dermatitis

N/A
Waitlist Available
Led By Richard R Anderson, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Having suitable areas of treatment: All wounds in the area of interest must be closed for at least two months. The scars must be deemed stable for a period of 3 months or have a suitable contralateral control before initiation of treatment. This will be determined by objective measurements of scar erythema, pliability, induration, thickness at enrollment and again at 3 months;
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This trial will test whether fractional laser treatment can improve the appearance and function of skin in people who have chronic radiation dermatitis from cancer treatment.

Who is the study for?
This trial is for healthy adults aged 18-80 with chronic skin damage from radiation, including fibrosis and depigmentation that occurred at least a year ago. Pregnant women can join as there are no new drugs involved. Participants must not have active cancer, be on certain chemotherapies, or have conditions affecting the study's safety.Check my eligibility
What is being tested?
The study tests if Fractional CO2 laser treatment (FLT) can reverse chronic skin damage caused by radiation therapy compared to no treatment. FLT aims to remodel scar tissue and restore normal skin functions in patients with long-term radiation dermatitis.See study design
What are the potential side effects?
While specific side effects of FLT aren't listed here, similar treatments may cause redness, swelling, pain at the site of application, changes in pigmentation, and a risk of infection or scarring.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My treatment area wounds have been closed for 2 months, and scars are stable or have a matching area to compare.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Improvement in fibrosis (% reduction in fibrosis surface area) compared to controlled sites
Secondary outcome measures
Adverse events

Trial Design

2Treatment groups
Experimental Treatment
Group I: No TreatmentExperimental Treatment1 Intervention
This is the area receiving no treatment.
Group II: Fractional CO2 laser TreatmentExperimental Treatment1 Intervention
This is the area getting treated with CO2 laser.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,928 Previous Clinical Trials
13,198,343 Total Patients Enrolled
Richard R Anderson, MDPrincipal InvestigatorMassachusetts General Hospital
4 Previous Clinical Trials
89 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Pilot Study of the Effect of Laser on Reversing Chronic Radiation Injury
Richard Rox Anderson, MD 2013. "Pilot Study of the Effect of Laser on Reversing Chronic Radiation Injury". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01910818.
All > Seborrheic Dermatitis > Alopecia
~1 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top